Menopause and ADHD: Why Symptoms May Shift and What Can Help

Why the menopause transition can make ADHD harder to manage

For women with attention deficit hyperactivity disorder (ADHD), perimenopause and menopause may bring changes in focus, memory, and organization that make everyday demands feel harder to handle. Falling estrogen levels are one possible part of the explanation, but research has not yet established exactly how hormonal changes affect ADHD symptoms.

ADHD affects about 6 percent of American adults and involves brain processes that support attention, impulse control, and emotional regulation. Symptoms can look different in women and men, which can affect whether ADHD is recognized. During the menopause transition, changing hormones may add to existing challenges, while disrupted sleep, stress, and competing responsibilities can make them more noticeable.

Estrogen, including estradiol, interacts with brain chemicals involved in cognitive function. Allison Deutch, MD, a clinical associate professor of psychiatry at NYU Grossman School of Medicine, says reduced estradiol may contribute to changes in executive function by influencing dopamine and glutamate in brain regions involved in thinking. That offers a possible biological link, but it doesn’t show that menopause causes ADHD or that every woman with ADHD will experience worsening symptoms. More research is needed to clarify the relationship.

Some women describe routines and coping systems that worked for years becoming less reliable. They may lose their train of thought in meetings, reread messages, or feel overwhelmed by tasks they once handled more easily. Lisa Saul, MD, chief medical officer of women’s health at UnitedHealth Group, points to the overlap between hormone changes and major life demands: work, household responsibilities, supporting children, and caring for older relatives can all compete for attention and energy.

Why ADHD may go unrecognized in women

Women entering menopause may not know they have ADHD. Childhood diagnosis rates cited in the source are 13 percent for boys and 7 percent for girls, but that difference doesn’t establish that ADHD is less common in girls. Research suggests that girls’ symptoms may be easier to miss because they often involve inattention, disorganization, and distractibility rather than conspicuous disruptive behavior.

Deutch explains that symptoms such as excessive talking, fidgeting, daydreaming, difficulty staying on task, or becoming quick to anger may be treated as personality traits instead of possible signs of ADHD. Girls and women who receive a diagnosis often do so later than boys and men.

Some women also develop detailed ways to compensate: calendars, reminders, routines, and backup plans. These tools can help someone meet daily responsibilities, but they may hide how much effort it takes to stay organized. A person who appears to be coping well may therefore go without an assessment until adulthood or midlife. A new or worsening difficulty with concentration doesn’t by itself establish ADHD, but discussing persistent changes with a healthcare professional can help clarify what may be contributing.

Supports to discuss with a clinician

There are several approaches to ADHD care, and the right combination depends on the person. Behavioral strategies are a core part of symptom support across ages. Calendars, planners, and timers can help externalize reminders and structure tasks. Reducing clutter in work and home spaces may also cut down on distractions. These tools can support daily functioning, although they won’t address every cause of attention or memory changes.

Cognitive behavioral therapy (CBT) is a psychotherapeutic approach used for ADHD. It can help people build coping strategies, work on time management, and address emotional challenges. Therapy may also offer a place to talk through difficulties that arise when ADHD and menopause overlap.

Medication is another option to discuss with a doctor. Common ADHD medicines include stimulants such as methylphenidate and amphetamine. Nonstimulant options include atomoxetine and some antidepressants. A 2026 medical conference presentation described an early scoping review suggesting that stimulant and nonstimulant ADHD medicines may have a role in menopause related executive dysfunction. That preliminary review does not establish how well these medicines work for this purpose, or which approach is suitable for a particular person. Medication choices and possible benefits and drawbacks need to be considered with a clinician.

Physical activity may support both ADHD symptoms and wellbeing during and after menopause. Deutch notes that exercise has been associated with improvements in ADHD symptoms. A study of more than 1,000 women ages 40 to 65 going through perimenopause or menopause found that activities including walking, dance, and yoga improved mood and quality of life. Those findings support exercise as a potential part of general wellbeing, but they don’t establish it as a substitute for other care.

Consider the whole picture

ADHD can occur alongside depression and anxiety, which are particularly relevant to consider in women. These conditions can make concentration more difficult, and treating them may ease some ADHD related challenges. Deutch also notes that addressing ADHD symptoms may lessen the burden of co-occurring mental health conditions in some cases. A healthcare professional can help assess overlapping concerns rather than assuming every change in focus or mood has one cause.

For women noticing changes in attention, memory, sleep, mood, or energy during the menopause transition, a conversation with a doctor can help sort through possible contributors and discuss support. The evidence on hormones and ADHD is still developing. In the meantime, a combination of practical tools, therapy, appropriate clinical care, and self-compassion may help make this demanding stage more manageable.